throbber
Biochem. J. (1997) 325, 707–710 (Printed in Great Britain)
`
`707
`
`Perturbation of the antigen-binding site and staphylococcal Protein
`A-binding site of IgG before significant changes in global conformation
`during denaturation: an equilibrium study
`Xi-De WANG*, Jie LUO*, Zhen-Quan GUO(cid:139), Jun-Mei ZHOU* and Chen-Lu TSOU*(cid:139)(cid:140)
`*National Laboratory of Biomacromolecules, Institute of Biophysics, Academia Sinica, Beijing 100101, China, and (cid:139)Department of Biology, Beijing University,
`Beijing 100871, China
`
`Although conformational perturbation of the active sites of
`many enzymes has been reported to precede global molecular
`conformational changes [Tsou (1993) Science 262, 380–381],
`little effort has been made to compare the susceptibility of the
`ligand-binding site of proteins and the protein molecules as a
`whole to perturbation by denaturants. Immunoglobulin is chosen
`in this study to address this problem. It is found that the variable
`and constant regions (Fv and Fc) of a monoclonal antibody of
`an IgG subclass against adenylate kinase lose their abilities to
`
`bind antigen and staphylococcal Protein A after treatment with
`guanidinium chloride concentrations considerably lower than
`those required to change the global conformation of the antibody
`as a whole, as detected by fluorescence and second-derivative UV
`absorption spectroscopy. These results indicate that both ligand-
`binding sites of the antibody concerned are more fragile than the
`molecule as a whole and that the Fv and Fc regions of the
`antibody molecule unfold sequentially during denaturation.
`
`INTRODUCTION
`Many enzymes had been reported to be inactivated by
`guanidinium chloride (GdmCl), urea or heat before gross mol-
`ecular conformational changes could be detected by conventional
`physicochemical methods [1–5] (for a review, see [5]). It has
`therefore been proposed that the active sites of enzymes are
`much more prone to perturbation during denaturation than the
`rest of the molecule [6]. However, the susceptibility to denaturants
`of the ligand-binding sites of proteins as compared with the
`global structure of the molecule has been little explored and it
`remains to be ascertained whether the functional sites of non-
`enzyme proteins are likewise more susceptible to perturbation
`than the molecules as a whole. Plasma fibronectin loses its
`agglutination activity at a lower temperature than that required
`to induce conformational changes as detected by its immuno-
`reactivity [7]. The inhibition of choline transport of the carrier
`protein in erythrocytes by n-alkanols involves the unfolding of a
`small but essential part of the molecule [8]. The interaction of the
`storage protein legumin from Vicia faba to form micelles was
`perturbed at urea concentrations lower than those required for
`global conformational changes of the molecule [9].
`Immunoglobulin is a Y-shaped molecule containing two
`ligand-binding sites, one for its specific antigen at the N-terminal
`variable region (Fv) and the other for staphylococcal Protein A
`(SpA) at the C-terminal CH2 and CH3 hinge region (Fc) [10]. In
`this investigation, changes in ligand-binding abilities of both the
`Fv and Fc regions of immunoglobulin are compared with global
`molecular conformational changes during denaturation in
`GdmCl of different concentrations.
`
`MATERIALS AND METHODS
`Reagents
`
`described previously [11]. Adenylate kinase was isolated from
`rabbit muscle [12]. Horseradish peroxidase-labelled SpA and
`goat anti-mouse IgG conjugate were purchased from Bio-Rad.
`Tetramethyl benzidine (TMB) was used as the substrate for
`horseradish peroxidase. GdmCl was an ultrapure product of
`Schwartz\Mann. Biotinamidocaproate N-hydroxysuccinimide
`ester (BNHS) and ExtrAvidin Peroxidase were purchased from
`Sigma. Avidin was the product of Serva. Other reagents were
`local products of analytical grade.
`
`Measurement of second-derivative absorption spectra
`Antibody at a final concentration of 175 lg\ml was incubated
`with different concentrations of GdmCl overnight at 4 mC. The
`second-derivative spectra were scanned at 20 mC using a Beckman
`DU-7500 spectrophotometer. The relative changes in the peak-
`to-trough distance between 287 and 283 nm of the second-
`derivative spectra in different concentrations of GdmCl were
`taken to represent exposure of the aromatic residues [13].
`
`Measurement of fluorescence
`Antibody at a final concentration of 16 lg\ml was incubated
`with different concentrations of GdmCl overnight at 4 mC. The
`intrinsic fluorescence emission spectra (excitation wavelength
`280 nm) between 300 and 400 nm were recorded at 20 mC with a
`Perkin–Elmer MPF-66 fluorescence spectrophotometer. The
`bandwidths for both excitation and emission were 10 nm. The
`shifts of maximum emission wavelength from native state were
`taken to represent the relative changes in fluorescence for
`denatured antibodies.
`
`Determination of Fc-binding activity
`
`The monoclonal antibody McAb3D3 of the IgG subclass was
`raised against adenylate kinase (EC 2;7;4;3), and purified as
`
`Binding of antibody McAb3D3 to horseradish peroxidase-
`labelled SpA was taken as a measure of the binding activity of
`
`Abbreviations used : Fc, constant region of IgG (CH2 and CH3 domains) ; Fv, variable region of IgG (VH and VL domains) ; GdmCl, guanidinium
`chloride ; PBST, PBS/Tween ; SpA, staphylococcal Protein A ; TMB, tetramethyl benzidine ; BNHS, biotinamidocaproate N-hydroxysuccinimide ester.
`(cid:140) To whom correspondence should be addressed.
`
`1 of 4
`
`Fresenius Kabi
`Exhibit 1038
`
`

`

`708
`
`X.-D. Wang and others
`
`the Fc region. The antibodies (McAb3D3) were first coated on to
`the wells of microplates by overnight incubation in PBS at 4 mC.
`Wells were then further treated with 5 mg\ml gelatin, after
`which GdmCl of different concentrations was added to wells in
`triplicate. The supernatants were decanted after 1 h of incubation
`and the wells thoroughly washed with PBST (0n5 % Tween 20 in
`PBS) to remove denaturants. Labelled SpA was then added and
`incubated for 1 h. After being rinsed three times with PBST,
`TMB solutions were added. Reactions were stopped by the
`addition of 100 ll of 2 M H
`. A
`SO
`of the TMB solution was
`%
`%&!
`#
`measured on a Bio-Rad 3550 microplate reader and found to be
`proportional to the amount of antibody applied per well over the
`range 0–0n1 lg per well. The amount of antibody that retained
`binding ability after treatment with GdmCl of different concentra-
`tions was quantified by comparison with standard curves.
`
`Determination of Fv-binding activity
`
`Biotinylation of adenylate kinase
`
`Biotinylated adenylate kinase was prepared by the method of
`Bonnard et al.
`[14]. The biotinylation reagent, BNHS, was
`dissolved in dimethylformamide to a final concentration of
`1 mg\ml as a stock solution. One volume of biotinylation reagent
`stock solution was mixed with 30 vol. of adenylate kinase (0n5–
`1n0 mg\ml in 0n1 M Na
`buffer, pH 9n0) and incubated
`HCO
`for 3 h. After overnight dialysis against 500 vol. of PBS at 4 mC,
`$
`an equal volume of glycerol was added to the dialysed solution,
`which was stored at k20 mC.
`
`#
`
`Determination of antibody-binding activity of biotinylated adenylate kinase
`Avidin (0n5 lg\100 ll\well) was adsorbed on to the microplates
`and the wells then blocked with 5 mg\ml gelatin. Biotinylated
`adenylate kinase of different concentrations was added to each
`well and incubated for 1 h. After three rinses with PBST,
`antibodies (McAb3D3) were added to each well and incubated
`for 1 h. After three similar rinses, 100 ll of horseradish
`peroxidase-labelled goat anti-mouse IgG conjugate (1 : 3000
`dilution) was added to each well, and incubated for 1 h. After
`rinsing, 100 ll of TMB solution was added. Reactions were
`stopped by the addition of 100 ll of 2 M H
`. A
`SO
`was
`%
`%&!
`#
`recorded on a Bio-Rad 3550 microplate reader and shown to be
`linear with the amount of biotinylated adenylate kinase over the
`range 0–50 lg\ml.
`
`Determination of Fv-binding activity
`
`Binding of antibody (McAb3D3) to biotin-labelled adenylate
`kinase was taken as a measure of the binding activity of the Fv
`region. The antibodies were first coated on to the microplates.
`The remaining non-specific binding sites on the wells were then
`blocked with 5 % gelatin. GdmCl of different concentrations was
`then added to the wells in triplicate, which were incubated for
`1n5 h, and then rinsed with PBST five times to remove the
`denaturant. Biotinylated adenylate kinase (100 ll) was added.
`After three rinses, 100 ll of ExtrAvidin Peroxidase (1 : 500
`dilution) was added and the mixture incubated for 30 min. After
`three rinses with PBST, 100 ll of TMB\H
`O
`solution was added
`and the reaction stopped after 10 min with 100 ll of 2 M H
`SO
`.
`%
`#
`The change in A
`was recorded on a Bio-Rad 3550 microplate
`%&!
`reader and shown to be linear with immunoglobulin over the
`range 0–0n12 lg\well.
`
`#
`
`#
`
`RESULTS
`Fluorescence emission spectra of native and denatured
`immunoglobulin
`
`To characterize the overall conformational changes in immuno-
`globulin in different concentrations of GdmCl, intrinsic fluores-
`cence and second-derivative absorption spectra were measured.
`The denatured protein shows increased emission intensity
`together with a shift in the emission maximum from 330 to
`350 nm, indicating a change in the microenvironment of the
`aromatic residues of the immunoglobulin molecule with an
`excitation wavelength of 280 nm (results not shown).
`
`Second-derivative spectra of native and denatured
`immunoglobulin
`
`The difference in peak-to-trough distance between 287 and
`283 nm represents a change in the microenvironment of tyrosine
`residues (results not shown).
`
`Conformational changes in immunoglobulin in different
`concentrations of GdmCl
`
`The relative changes in the shift in emission maximum of the
`intrinsic fluorescence spectra and the peak-to-trough distance of
`the second-derivative spectra of immunoglobulin in GdmCl of
`different concentrations are shown in Figure 1. The maximum
`emission wavelength of native immunoglobulin at 330 nm is
`shifted gradually to longer wavelengths during denaturation,
`reaching 350 nm in 5 M GdmCl. Little shift in maximum emission
`wavelength can be observed in GdmCl concentrations lower than
`1n5 M, and significant shifts take place between 1n5 and 2n8 M,
`with the concentration of GdmCl required to bring a 50 % shift
`in emission maximum at approx. 2n3 M. The second-derivative
`spectra of immunoglobulin do not change in GdmCl concentra-
`
`100
`
`,....
`~
`CD
`:::,
`0
`>
`CD
`>
`:;:;
`0
`CD
`0::
`
`80
`
`60
`
`40
`
`20
`
`0
`
`0
`
`2
`
`4
`
`[GuHCI] (M)
`
`6
`
`Figure 1 Relative changes in fluorescence, second-derivative spectra and
`antigen-binding activities of the Fc and Fv parts of McAb3D3 in GdmCl
`(GuHCl) of different concentrations
`
`Curve 1, relative shift of fluorescence emission maximum wavelength ; curve 2, relative values
`of peak-to-trough distance between 287 and 283 nm of second-derivative absorption spectra ;
`curve 3, relative activity of Fc region of McAb3D3 ; curve 4, relative activity of Fv region of
`McAb3D3.
`
`2 of 4
`
`Fresenius Kabi
`Exhibit 1038
`
`

`

`tions lower than 1 M. The peak-to-trough distance changes
`sharply between 2n2 and 3n1 M GdmCl, with a transition point at
`2n7 M. The immunoglobulin is unfolded almost completely in
`3n5 M GdmCl. The fluorescence and second-derivative spectra
`monitor the structural environment of the aromatic residues in
`the molecule,
`the latter being more sensitive to micro-
`environmental changes in tyrosine residues and the former more
`sensitive to those of tryptophan residues.
`
`Change in activity of Fc region of McAb3D3 in GdmCl
`
`The Fc part of an immunoglobulin comprises the two C-terminal
`constant regions of the heavy chains that interact with the
`complement system and with specific receptors on the surface of
`a variety of cells. Part of the polypeptide chain of SpA is a series
`of four highly homologous regions [15] each of which is able to
`bind to the Fc part of IgG from various species. The structure of
`the complex formed by human Fc fragment and fragment B of
`Protein A has been determined to high resolution by Deisenhofer
`[10]. In this study, changes in binding of the Fc region of
`McAb3D3 to SpA in different concentrations of GdmCl were
`followed by monitoring the binding to horseradish peroxidase-
`labelled SpA. The amount of functionally reactive antibody
`remaining after treatment with GdmCl of different concentra-
`tions was quantified by comparison with standard curves obtained
`in the absence of GdmCl. Figure 1 curve 3 shows the percentage
`of Fc region that remains capable of binding to SpA after
`denaturation. It is clear that the SpA-binding ability of Fc is
`affected by GdmCl at relatively low concentrations. The con-
`centration of GdmCl required to inactivate the Fc part of
`immunoglobulin by 50 % is about 1n0 M, and the ability of the
`Fc region to bind to SpA is completely destroyed at GdmCl
`concentrations higher than 2 M.
`
`Change in the activity of the Fv part of McAb3D3 in GdmCl
`
`The Fv part of an immunoglobulin contains its specific antigen-
`binding site. Several structures of the antigen-bound Fab frag-
`ment have been determined [16]. For measurement of the binding
`ability of McAb3D3 to adenylate kinase as its antigen by indirect
`ELISA, biotinylated adenylate kinase was prepared and tested
`by ELISA to ensure the immunoreactivity of the conjugates (see
`the Materials and methods section). The results show that the
`binding of biotinylated adenylate kinase to McAb3D3 is pro-
`portional to the amount of biotinylated adenylate kinase. In this
`study, changes in binding of the Fv region of McAb3D3 to
`adenylate kinase after treatment with different concentrations of
`GdmCl were followed by monitoring binding to biotinylated
`adenylate kinase. Figure 1 curve 4 shows the relative percentage
`of Fv region that retains its ability to bind to adenylate kinase.
`It is evident that the Fv region loses its ability to bind to
`adenylate kinase by 50 % at a GdmCl concentration of 0n18 M,
`which is much lower than that required to bring about conforma-
`tional changes in both the Fc region (Figure 1 curve 3) and the
`molecule as a whole, as detected by fluorescence and second-
`derivative spectra (Figure 1 curves 1 and 2). Although it
`could be objected that some refolding of the denatured antibody
`might have occurred with partial recovery of antigen-binding
`activity after GdmCl was washed out, if some re-activation had
`occurred, this could only result in, if anything, an overestimation
`of the antigen-binding activity remaining, making the difference
`in GdmCl concentration required to bring about conformational
`changes and inactivation of the antibody even greater.
`
`Denaturation of IgG
`
`709
`
`DISCUSSION
`Sequential conformational changes during unfolding
`
`The two-state model has been the dominant theory of protein
`folding for several decades. This is based on the experimental
`results of identical relative changes in conformation as measured
`by different methods during the folding–unfolding transitions
`[17]. In recent years, technical progress in both kinetic and
`equilibrium studies of protein folding and unfolding has revealed
`the existence of relatively stable intermediates [18]. Several folding
`intermediates of Fab and Fabalk have been recognized by Lilie et
`al. [19], and the denaturation kinetics of its antigen-binding
`activity for both Fab and Fabalk have also been compared [20].
`These authors found that the rate of loss of its antigen-binding
`activity, as measured by ELISA, is much faster than that of its
`secondary structure, as measured by CD, and concluded that the
`correct quaternary structure of Fab disappeared first, followed
`by a loss of secondary structure. In the present study, the
`activities of the Fv and Fc regions of immunoglobulin are
`separately compared with global conformational changes of the
`molecule in GdmCl of different concentrations. The transition
`points of the overall conformational change in immunoglobulin
`McAb3D3 with increasing concentrations of GdmCl differ
`significantly as detected by second-derivative spectroscopy and
`by fluorescence. The difference suggests that the unfolding of
`immunoglobulin does not follow an ‘ all or none ’ model. More-
`over, the Fc and Fv regions are inactivated at much lower
`GdmCl concentrations, 1n0 and 0n18 M respectively, than required
`for the overall conformational change, suggesting that the
`perturbation of the antigen-binding site and SpA-binding site
`precedes overall changes in conformation during GdmCl de-
`naturation. With increasing GdmCl concentrations, the antigen-
`binding site is affected first, followed by the SpA-binding site,
`and the overall conformational change takes place last. This
`indicates a non-parallel sequential unfolding between sub-
`domains of the immunoglobulin molecule.
`
`The Fv and Fc regions are more fragile than the immunoglobulin
`molecule as a whole
`
`Although previous studies in this laboratory have shown that the
`active sites of many enzymes are more fragile than the molecules
`as a whole [6],
`little effort has been made to compare the
`susceptibility of the ligand-binding site of proteins and the
`overall structure of protein molecules. From the results presented
`above, it appears that, like many enzymes, the ligand-binding
`sites of immunoglobulin are also more fragile than the molecule
`as a whole. The substrate-binding sites of many enzymes are
`situated in the cleft region between domains [21], whereas
`in immunoglobulins, antigens bind to the interfaces composed of
`the N-terminal domains of the light and heavy chains, and the
`SpA-binding site consists of residues from the CH2 and CH3
`domains of immunoglobulin heavy chain [8]. The resemblance of
`ligand-binding sites of enzyme and non-enzyme proteins is further
`illustrated in the structure of the catalytic sites of abzymes by the
`transformation of the non-catalytic binding site of immuno-
`globulin to the catalytic site of an enzyme without marked
`alterations in other regions of the same molecule [22].
`The conformation of the protein macromolecule is held
`together by a large number of weak bonds either of different
`nature or of similar nature but with different environments and
`consequently different in stability ; protein unfolding is of necess-
`ity a complicated process. At low concentrations of some
`denaturants, the disruption of some particularly susceptible
`
`3 of 4
`
`Fresenius Kabi
`Exhibit 1038
`
`

`

`710
`
`X.-D. Wang and others
`
`bonds, essential to keep the enzyme or protein in an active state,
`inactivates the enzyme without conspicuous structural changes.
`Results presented in the present study indicate that the unfolding
`of a non-enzyme protein, immunoglobulin, is likewise a sequen-
`tial or stepwise process, and its Fv and Fc regions are more easily
`perturbed than the molecule as a whole.
`
`We are grateful to Dr. H. J. Zhang for providing adenylate kinase. This work was
`supported in part by the Pandeng Project of the China National Commission of
`Science and Technology.
`
`1
`2
`3
`4
`
`REFERENCES
`Yao, Q. Z., Tian, M. and Tsou, C. L. (1984) Biochemistry 23, 2740–2744
`Liu, W. and Tsou, C. L. (1987) Biochim. Biophys. Acta 916, 455–464
`Xie, G. F. and Tsou, C. L. (1987) Biochim. Biophys. Acta 911, 19–24
`Zhang, Y. L., Zhou, J. M. and Tsou, C. L. (1993) Biochim. Biophys. Acta 1164,
`61–67
`Tsou, C. L. (1995) Biochim. Biophys. Acta 1253, 151–162
`Tsou, C. L. (1993) Science 282, 380–381
`
`5
`6
`
`Received 23 September 1996/21 March 1997 ; accepted 25 March 1997
`
`13
`
`14
`
`8
`9
`
`7 Wallace, D. G., Donovan, J. W., Schncider, P. M., Meunier, A. M. and Lundblad, J. L.
`(1981) Arch. Biochem. Biophys. 212, 515–524
`Deve! s, R. and Krupka, R. M. (1990) Biochim. Biophys. Acta 1030, 32–40
`Ismond, M. A. H., Georgiou, C., Arntfield, S. D. and Murray, E. D. (1990) J. Food Sci.
`55, 1638–1642
`10 Deisenhofer, J. (1981) Biochemistry 20, 2361–2370
`11 Wang, X. D., Zhou, J. M. and Guo, Z. Q. (1997) Sci. China, in the press
`12 Heil, A., Muller, G., Noda, L., Pinder, T., Schirmer, H., Schirmer, I. and Zabern, I. V.
`(1974) Eur. J. Biochem. 43, 131–144
`Ragone, R., Colonna, G., Balestrieri, C., Servillo, L. and Irace, G. (1984) Biochemistry
`23, 1871–1875
`Bonnard, C., Papermaster, D. S. and Kraehenbuhl, J. P. (1984) in Immunolabelling for
`Electron Microscopy (Polak, J. M. and Varndell, I. M., eds.), pp. 95–111, Elsevier
`Scientific Publishers, Amsterdam
`Sjodahl, J. (1977) Eur. J. Biochem. 78, 471–491
`15
`Stanfield, R. L. and Wilson, I. A. (1994) Science 12, 275–279
`16
`Tanford, C. (1970) Adv. Protein Chem. 24, 1–95
`17
`Christensen, H. and Pain, R. H. (1991) Eur. Biophys. J. 19, 221–229
`18
`Lilie, H., Rudolph, R. and Buchner, J. (1995) J. Mol. Biol. 248, 190–201
`19
`Lilie, H., Jaenicke, R. and Buchner, J. (1995) Protein Sci. 4, 917–924
`20
`21 Weaver, L. H. and Matthews, B. W. (1987) J. Mol. Biol. 193, 189–199
`Jacobsen, J. R. and Schultz, P. G. (1995) Curr. Opin. Struct. Biol. 5, 818–824
`22
`
`4 of 4
`
`Fresenius Kabi
`Exhibit 1038
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket